ID

34387

Beschrijving

Influence of Probiotics Administration Before Liver Resection in Liver Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02021253

Link

https://clinicaltrials.gov/show/NCT02021253

Trefwoorden

  1. 17-01-19 17-01-19 -
  2. 07-10-20 07-10-20 -
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

17 januari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Liver Fibrosis NCT02021253

Eligibility Liver Fibrosis NCT02021253

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
agreement signed by the patient
Beschrijving

ID.1

Datatype

boolean

diagnosis of hcc confirmed
Beschrijving

ID.2

Datatype

boolean

diagnosis of liver disease (score f3 or f4) confirmed
Beschrijving

ID.3

Datatype

boolean

indication of surgical resection confirmed and validated by a specialist multidisciplinary assessment meeting of gastrointestinal oncology
Beschrijving

ID.4

Datatype

boolean

patient operable (no indication against anaesthesiological)
Beschrijving

ID.5

Datatype

boolean

resectable tumor lesion (surgical expertise)
Beschrijving

ID.6

Datatype

boolean

laboratory tests and endoscopy: no suspicion of severe portal hypertension with bleeding risk
Beschrijving

ID.7

Datatype

boolean

Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
patient not willing, at risk of default of compliance, or patient can not be monitored regularly
Beschrijving

ID.8

Datatype

boolean

antibiotic extended or terminated for less than 1 month, may limit the effects of taking probiotics.
Beschrijving

ID.9

Datatype

boolean

inflammatory bowel disease, which could skew the results expected by taking probiotics results.
Beschrijving

ID.10

Datatype

boolean

Similar models

Eligibility Liver Fibrosis NCT02021253

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
agreement signed by the patient
boolean
ID.2
Item
diagnosis of hcc confirmed
boolean
ID.3
Item
diagnosis of liver disease (score f3 or f4) confirmed
boolean
ID.4
Item
indication of surgical resection confirmed and validated by a specialist multidisciplinary assessment meeting of gastrointestinal oncology
boolean
ID.5
Item
patient operable (no indication against anaesthesiological)
boolean
ID.6
Item
resectable tumor lesion (surgical expertise)
boolean
ID.7
Item
laboratory tests and endoscopy: no suspicion of severe portal hypertension with bleeding risk
boolean
Item Group
C0680251 (UMLS CUI)
ID.8
Item
patient not willing, at risk of default of compliance, or patient can not be monitored regularly
boolean
ID.9
Item
antibiotic extended or terminated for less than 1 month, may limit the effects of taking probiotics.
boolean
ID.10
Item
inflammatory bowel disease, which could skew the results expected by taking probiotics results.
boolean

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial